A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

The buzz at the Golden Globes wasn't about who was best dressed; it was about how obvious the Ozempic look has become, writes ...

Claiming Science magazine's breakthrough of the year in 2023 , these drugs are an absolute revelation: they give you long-lasting weight loss as long as you continue taking them .

Novo Nordisk (NOVO) is petitioning the FDA to exclude its diabetes drug liraglutide, also known as Victoza, from a list of ...

Novo Nordisk (NVO) markets liraglutide under the brand names Victoza, Saxenda and Xultophy. The drug is currently on the FDA's drug shortage list. Compounding pharmacies are allowed to make ...

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making ...

But the JPML ruled that adding those new injuries would make the litigation significantly ... The inclusion of Novo Nordisk’s Saxenda brings the number of GLP-1 RA products in the litigation ...

The generic liraglutide is sold by Hikma Pharmaceuticals USA, and a spokesman told CNN by email that the company expects to make the drug ... called Saxenda. “There are many people on this ...